Cargando…
Switching costs in competitive health insurance markets: The role of insurers' pricing strategies
Our article deals with pricing strategies in Swiss health insurance markets and focuses on the relationship between basic and supplementary insurance. We analyzed how firms' pricing strategies (i.e., pricing of basic and supplementary products) can create switching costs in basic health insuran...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496908/ https://www.ncbi.nlm.nih.gov/pubmed/32542729 http://dx.doi.org/10.1002/hec.4111 |
_version_ | 1783583202307211264 |
---|---|
author | Lamiraud, Karine Stadelmann, Pierre |
author_facet | Lamiraud, Karine Stadelmann, Pierre |
author_sort | Lamiraud, Karine |
collection | PubMed |
description | Our article deals with pricing strategies in Swiss health insurance markets and focuses on the relationship between basic and supplementary insurance. We analyzed how firms' pricing strategies (i.e., pricing of basic and supplementary products) can create switching costs in basic health insurance markets, thereby preventing competition in basic insurance from working properly. More specifically, using unique market and survey data, we investigated whether firms use bundling strategies or supplementary products as low‐price products to attract and retain basic insurance consumers. To our knowledge, this is the first paper to analyze these pricing strategies in the context of insurance/health insurance. We found no evidence of bundling in the Swiss setting. We did however observe that firms used low‐price supplementary products that contributed to lock in consumers. A majority of firms offered at least one of such product at a low price. None offered low‐price products in both basic and supplementary markets. Low‐price insurance products differed across firms. When buying a low‐price supplementary product, consumers always bought their basic contract from the same firm. Furthermore, those who opted for low‐price supplementary products were less likely to declare an intention to switch basic insurance firms in the near future. This result was true for all risk category levels. |
format | Online Article Text |
id | pubmed-7496908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74969082020-09-25 Switching costs in competitive health insurance markets: The role of insurers' pricing strategies Lamiraud, Karine Stadelmann, Pierre Health Econ Research Articles Our article deals with pricing strategies in Swiss health insurance markets and focuses on the relationship between basic and supplementary insurance. We analyzed how firms' pricing strategies (i.e., pricing of basic and supplementary products) can create switching costs in basic health insurance markets, thereby preventing competition in basic insurance from working properly. More specifically, using unique market and survey data, we investigated whether firms use bundling strategies or supplementary products as low‐price products to attract and retain basic insurance consumers. To our knowledge, this is the first paper to analyze these pricing strategies in the context of insurance/health insurance. We found no evidence of bundling in the Swiss setting. We did however observe that firms used low‐price supplementary products that contributed to lock in consumers. A majority of firms offered at least one of such product at a low price. None offered low‐price products in both basic and supplementary markets. Low‐price insurance products differed across firms. When buying a low‐price supplementary product, consumers always bought their basic contract from the same firm. Furthermore, those who opted for low‐price supplementary products were less likely to declare an intention to switch basic insurance firms in the near future. This result was true for all risk category levels. John Wiley and Sons Inc. 2020-06-15 2020-09 /pmc/articles/PMC7496908/ /pubmed/32542729 http://dx.doi.org/10.1002/hec.4111 Text en © 2020 The Authors. Health Economics published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Lamiraud, Karine Stadelmann, Pierre Switching costs in competitive health insurance markets: The role of insurers' pricing strategies |
title | Switching costs in competitive health insurance markets: The role of insurers' pricing strategies |
title_full | Switching costs in competitive health insurance markets: The role of insurers' pricing strategies |
title_fullStr | Switching costs in competitive health insurance markets: The role of insurers' pricing strategies |
title_full_unstemmed | Switching costs in competitive health insurance markets: The role of insurers' pricing strategies |
title_short | Switching costs in competitive health insurance markets: The role of insurers' pricing strategies |
title_sort | switching costs in competitive health insurance markets: the role of insurers' pricing strategies |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496908/ https://www.ncbi.nlm.nih.gov/pubmed/32542729 http://dx.doi.org/10.1002/hec.4111 |
work_keys_str_mv | AT lamiraudkarine switchingcostsincompetitivehealthinsurancemarketstheroleofinsurerspricingstrategies AT stadelmannpierre switchingcostsincompetitivehealthinsurancemarketstheroleofinsurerspricingstrategies |